Showing results (1391-1400 of 1,615) with videos related to

Sort By:
Pageof 162
European Radiology|February 7, 2018
Dual-energy CT: a phantom comparison of different platforms for abdominal imagingThorsten Sellerer, Peter B Noël, Manuel Patino, et al.
European Radiology|May 23, 2019
Bone mineral density measurements derived from dual-layer spectral CT enable opportunistic screening for osteoporosisFerdinand Roski, Johannes Hammel, Kai Mei, et al.
Synapse (New York, N.Y.)|November 19, 2008
Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned place preferenceAmy DeMarco, Reema M Dalal, Jessica Pai, et al.
Gastrointestinal Endoscopy|June 16, 2014
Volatile organic compounds in bile can diagnose malignant biliary strictures in the setting of pancreatic cancer: a preliminary observationUdayakumar Navaneethan, Mansour A Parsi, Norma G Gutierrez, et al.
Thescientificworldjournal|September 27, 2021
Associations of Air Pollution and Pediatric Asthma in Cleveland, OhioSumita B Khatri, Cynthia Newman, Jeffrey P Hammel, et al.
Scientific Reports|October 12, 2022
Five material tissue decomposition by dual energy computed tomographyMaximilian E Lochschmidt, Melina Gassenhuber, Isabelle Riederer, et al.
Nature Communications|July 14, 2022
A monomeric mycobacteriophage immunity repressor utilizes two domains to recognize an asymmetric DNA sequenceReliza J McGinnis, Chad A Brambley, Brandon Stamey, et al.
Archives of Physical Medicine and Rehabilitation|June 26, 2016
Measuring Environmental Factors: Unique and Overlapping International Classification of Functioning, Disability and Health Coverage of 5 InstrumentsAllen W Heinemann, Ana Miskovic, Patrick Semik, et al.
Gut|October 16, 2010
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)Laetitia Dahan, Frank Bonnetain, Marc Ychou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II studyJean-Luc Van Laethem, Pascal Hammel, Françoise Mornex, et al.
Pageof 162